Michelle Dalton, ELS
The ASRS Global Trends Survey finds differences in some treatment preferences
This year’s ASRS PAT survey show subtle regional differences
An expanded indication for aflibercept injection (Eylea, Regeneron) is now approved by the FDA to treat all stages of diabetic retinopathy (DR).
Group of researchers aim to validate both approaches in proof-of-concept study
Ongoing treatment with anti-vascular endothelial growth factor (VEGF) injections or photodynamic therapy (verteporfin) is, to date, the primary means of managing and treating AMD.
With no “cure,” neovascular age-related macular degeneration (or wet AMD) remains a key disease state for numerous pharmaceutical companies.
About 85% to 90% of the cases of age-related macular degeneration (AMD) are the “dry” (atrophic) type.